# Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

> **NCT01693549** · PHASE2 · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 84 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Cabazitaxel

## Key facts

- **NCT ID:** NCT01693549
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2017-07-10
- **Final completion:** 2017-07-20
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01693549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01693549, "Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01693549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*